Item

Magnesium Oxide Powder Low (21071)

Refer to ingredient statement.
Food Ingredient
Attributes
  • Gluten-free
  • Ingredient declaration
Locations
Location name Address
Tomita Pharmaceutical Co., Ltd. 85-1, Maruyama, Akinokami, Seto-cho Naruto, 36 7710360 JPN
Documents
Type Location File name Effective Expiration
HACCP Tomita Pharmaceutical Co., Ltd. !Confidential Document - TRACEGAINS RESPONSE 022224.pdf 9/16/2024 9/16/2027
CoA Sample Tomita Pharmaceutical Co., Ltd. _Control COA 21071-58463 - Magnesium Oxide Powder - 25 KG Bag D1-24 R4-24 (ID 2993265).pdf 5/29/2024 5/29/2026
Heavy Metal Tomita Pharmaceutical Co., Ltd. _Control COA 21071-58463 - Magnesium Oxide Powder - 25 KG Bag R6-22 (ID 2264276).pdf 8/9/2022 8/8/2024
GRAS/NDI/ODI Statement Tomita Pharmaceutical Co., Ltd. 21071 GRAS Status D8-22 R8-22 (ID 2311597).pdf 7/15/2024 7/15/2027
Halal Tomita Pharmaceutical Co., Ltd. 21071 Halal Certificate Exp 5-23-24 (ID 2839663).pdf 5/23/2023 5/23/2024
Pesticide Tomita Pharmaceutical Co., Ltd. 21071 Pesticides D11-21 R12-21 (ID 2203217).pdf 12/14/2023 12/13/2025
California Prop. 65 Tomita Pharmaceutical Co., Ltd. 21071 Prop 65 D11-22 R5-23 (ID 2609446).pdf 11/22/2023 11/21/2025
Sewage Statement Tomita Pharmaceutical Co., Ltd. 21071 Sewage Sludge D11-21 R12-21 (ID 2036512).pdf 11/22/2023 11/21/2025
Animal Testing Statement Tomita Pharmaceutical Co., Ltd. 21071-51263 Animal Testing; Vegan; Vegetarian D5-22 R5-22 (ID 2203231).pdf 7/17/2023 7/17/2024
Ingredient Statement Tomita Pharmaceutical Co., Ltd. 21071-51263 Composition D9-21 R9-21 (ID 2038397).pdf 7/18/2023 7/17/2024
Natural Tomita Pharmaceutical Co., Ltd. 21071-51263 Flow Chart D11-22 R5-23 (ID 2609449).pdf 4/16/2024 4/16/2025
HACCP Process Flow Diagram Tomita Pharmaceutical Co., Ltd. 21071-51263 Flow Chart D11-22 R5-23 (ID 2609449).pdf 9/20/2024 9/20/2026
Gluten Tomita Pharmaceutical Co., Ltd. 21071-51263 Gluten D11-21 R12-21 (ID 2203200).pdf 8/10/2023 8/9/2024
GMO Tomita Pharmaceutical Co., Ltd. 21071-51263 GMO D5-21 R5-21 (ID 2203201).pdf 7/18/2023 7/17/2025
EtO Statement Tomita Pharmaceutical Co., Ltd. 21071-51263 Irradiation; ETO D11-21 R12-21 (ID 2203205).pdf 11/18/2022 11/18/2023
Irradiation Status Statement Tomita Pharmaceutical Co., Ltd. 21071-51263 Irradiation; ETO D11-21 R12-21 (ID 2203205).pdf 11/22/2023 11/21/2025
Melamine Tomita Pharmaceutical Co., Ltd. 21071-51263 Melamine D11-21 R12-21 (ID 2036652).pdf 2/2/2023 2/2/2024
Label Sample Tomita Pharmaceutical Co., Ltd. 21071-51263 Product Picture Product Label R8-18 ID 2203221.pdf 6/21/2022 6/21/2023
Residual Statement Tomita Pharmaceutical Co., Ltd. 21071-51263 Residual Solvents D11-21 R12-21 (ID 2036518).pdf 2/27/2023 2/27/2024
BSE - TSE Tomita Pharmaceutical Co., Ltd. 21071-58463 BSE-TSE Animal Testing D11-21 R12-21 ID 2203239.pdf 6/8/2022 6/7/2025
Vegan/Vegetarian Statement Tomita Pharmaceutical Co., Ltd. 21071-58463 BSE-TSE Animal Testing D11-21 R12-21 ID 2203239.pdf 7/6/2022 7/5/2024
HARPC Food Safety Plan (Item) Tomita Pharmaceutical Co., Ltd. 21071-58463 Flow Chart (HACCP) R12-21 (ID 2203246).pdf 9/12/2024 9/12/2027
Safety Data Sheet (SDS) Tomita Pharmaceutical Co., Ltd. 21071-58463 Safety Data Sheet (SDS) D7-20 (ID 2203266).pdf 12/14/2023 12/13/2025
WADA/NSF/NFL Statement Tomita Pharmaceutical Co., Ltd. 21071-58463 WADA D2-21 R2-21 ID 2203273.pdf 6/8/2022 6/7/2024
Allergens Tomita Pharmaceutical Co., Ltd. Allergens.pdf 1/28/2022 1/28/2024
Country of Origin Tomita Pharmaceutical Co., Ltd. Country of Origin.pdf 1/31/2022 1/30/2025
National Bioengineered Food Disclosure Standard (Simplified) Tomita Pharmaceutical Co., Ltd. National Bioengineered Food Disclosure Standard (Simplified).pdf 7/22/2022 7/21/2025
Allergens EU/UK Tomita Pharmaceutical Co., Ltd. NotApplicable_AllergensEUUK.pdf 6/8/2022 6/7/2024
Country of Origin EU/UK Tomita Pharmaceutical Co., Ltd. NotApplicable_CountryofOriginEUUK.pdf 6/8/2022 6/7/2025
Nutrition EU/UK Tomita Pharmaceutical Co., Ltd. NotApplicable_NutritionEUUK.pdf 6/8/2022 6/7/2025
Organic Tomita Pharmaceutical Co., Ltd. NotApplicable_Organic.pdf 7/19/2023 7/19/2024
Nutrition Tomita Pharmaceutical Co., Ltd. Nutrition.pdf 1/28/2022 1/27/2025